ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NVTA Invitae Corporation

0.0891
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Invitae Corporation NYSE:NVTA NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0891 0 01:00:00

Current Report Filing (8-k)

27/10/2016 1:01pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities and Exchange Act of 1934

 

Date of Report:   October 27, 2016

(Date of earliest event reported)

 

Invitae Corporation

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-36847

 

27-1701898

(State or other jurisdiction of

 

(Commission File Number)

 

(I.R.S. employer

incorporation or organization)

 

 

 

identification number)

 

458 Brannan Street, San Francisco, California 94107

(Address of principal executive offices, including zip code)

 

(415) 374-7782
(Registrant’s telephone number, including area code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

o              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o              Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o              Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 8.01                                            Other Events.

 

Invitae Corporation announced that it entered into a national provider agreement for laboratory services with Humana, effective December 1, 2016.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated:  October 27, 2016

 

 

INVITAE CORPORATION

 

 

 

 

 

 

 

By:

/s/ Lee Bendekgey

 

Name:

Lee Bendekgey

 

Title:

Chief Financial Officer, General Counsel and Secretary

 

3


1 Year Invitae Chart

1 Year Invitae Chart

1 Month Invitae Chart

1 Month Invitae Chart